These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study. Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011 [TBL] [Abstract][Full Text] [Related]
3. Levetiracetam monotherapy in children with epilepsy. Khurana DS; Kothare SV; Valencia I; Melvin JJ; Legido A Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904 [TBL] [Abstract][Full Text] [Related]
4. Levetiracetam in absence epilepsy. Verrotti A; Cerminara C; Domizio S; Mohn A; Franzoni E; Coppola G; Zamponi N; Parisi P; Iannetti P; Curatolo P Dev Med Child Neurol; 2008 Nov; 50(11):850-3. PubMed ID: 18808424 [TBL] [Abstract][Full Text] [Related]
5. Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents. Verrotti A; Cerminara C; Coppola G; Franzoni E; Parisi P; Iannetti P; Aloisi P; Tozzi E; Cusmai R; Vigevano F; Chiarelli F; Curatolo P Dev Med Child Neurol; 2008 Jan; 50(1):29-32. PubMed ID: 18173626 [TBL] [Abstract][Full Text] [Related]
6. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial. Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM; Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study. Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083 [TBL] [Abstract][Full Text] [Related]
8. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures. Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B; Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423 [TBL] [Abstract][Full Text] [Related]
9. Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study. Delanty N; Jones J; Tonner F Epilepsia; 2012 Jan; 53(1):111-9. PubMed ID: 22050371 [TBL] [Abstract][Full Text] [Related]
10. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Glauser TA; Ayala R; Elterman RD; Mitchell WG; Van Orman CB; Gauer LJ; Lu Z; Neurology; 2006 Jun; 66(11):1654-60. PubMed ID: 16641323 [TBL] [Abstract][Full Text] [Related]
11. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures. Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175 [TBL] [Abstract][Full Text] [Related]
12. Adjunctive levetiracetam in patients aged 1 month to <4 years with partial-onset seizures: subpopulation analysis of a prospective, open-label extension study of up to 48 weeks. Piña-Garza JE; Schiemann-Delgado J; Yang H; Duncan B; Hadac J; Hunter SJ Clin Ther; 2010 Oct; 32(11):1935-50. PubMed ID: 21095488 [TBL] [Abstract][Full Text] [Related]
13. Effects of levetiracetam on EEG abnormalities in juvenile myoclonic epilepsy. Specchio N; Boero G; Michelucci R; Gambardella A; Giallonardo AT; Fattouch J; Di Bonaventura C; de Palo A; Ladogana M; Lamberti P; Vigevano F; La Neve A; Specchio LM Epilepsia; 2008 Apr; 49(4):663-9. PubMed ID: 18266754 [TBL] [Abstract][Full Text] [Related]
14. Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA). Stefan H; Wang-Tilz Y; Pauli E; Dennhöfer S; Genow A; Kerling F; Lorber B; Fraunberger B; Halboni P; Koebnick C; Gefeller O; Tilz C Epilepsia; 2006 Mar; 47(3):516-22. PubMed ID: 16529615 [TBL] [Abstract][Full Text] [Related]
15. Levetiracetam monotherapy for late poststroke seizures in the elderly. Kutlu G; Gomceli YB; Unal Y; Inan LE Epilepsy Behav; 2008 Oct; 13(3):542-4. PubMed ID: 18539085 [TBL] [Abstract][Full Text] [Related]
16. Levetiracetam as add-on therapy in different subgroups of "benign" idiopathic focal epilepsies in childhood. von Stülpnagel C; Kluger G; Leiz S; Holthausen H Epilepsy Behav; 2010 Feb; 17(2):193-8. PubMed ID: 20045383 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of levetiracetam in the treatment of drug-resistant Rett syndrome. Specchio N; Balestri M; Striano P; Cilio MR; Nardello R; Patanè S; Margiotta ML; D'Orsi G; Striano S; Russo S; Specchio LM; Cusmai R; Fusco L; Vigevano F Epilepsy Res; 2010 Feb; 88(2-3):112-7. PubMed ID: 19914805 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review. Perry MS; Benatar M Epilepsia; 2007 Jun; 48(6):1123-7. PubMed ID: 17430408 [TBL] [Abstract][Full Text] [Related]
19. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy. Steinhoff BJ; Somerville ER; Van Paesschen W; Ryvlin P; Schelstraete I Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453 [TBL] [Abstract][Full Text] [Related]
20. Levetiracetam: a long-term follow-up study of efficacy and safety. Bauer J; Ben-Menachem E; Krämer G; Fryze W; Da Silva S; Kasteleijn-Nolst Trenité DG Acta Neurol Scand; 2006 Sep; 114(3):169-76. PubMed ID: 16911344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]